| NCT ID | NCT05764681 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chantel Burkitt |
| Condition | Cerebral Palsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-03-17 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-03-17 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study purpose is to document the typical trajectory of perioperative pain experience in Cerebral Palsy (CP) and to identify important predictive factors for the development of chronic postsurgical pain. The main aims of the investigators are to: 1. Quantify the trajectory of pain and opioid use in the context of orthopedic surgery in children with CP. 2. Identify predictors for CPSP in children with CP and develop an applicable risk index. 3. Examine relationships between perioperative pain severity and functional/mobility outcomes achieved by orthopedic surgery in children with CP. Participants will complete: 1. Questionnaires/Surveys via email and text message 2. In-person Sensory Tests 3. In-person Gait and Motion Analysis
Eligibility Criteria
Inclusion Criteria: * CP diagnosis * Have a scheduled lower extremity or spine orthopedic surgery Exclusion Criteria: * Non-English speaking and reading parent/guardian
Contact & Investigator
Chantel Burkitt, PhD
PRINCIPAL INVESTIGATOR
Gillette Children's, University of Minnesota
Frequently Asked Questions
Who can join the NCT05764681 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 17 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05764681 currently recruiting?
Yes, NCT05764681 is actively recruiting participants. Contact the research team at maykalajowens@gillettechildrens.com for enrollment information.
Where is the NCT05764681 trial being conducted?
This trial is being conducted at Wilmington, United States, Saint Paul, United States.
Who is sponsoring the NCT05764681 clinical trial?
NCT05764681 is sponsored by Chantel Burkitt. The principal investigator is Chantel Burkitt, PhD at Gillette Children's, University of Minnesota. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.